MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-08-2026
InfuSystem Holdings Interest Expense 2011-2026 | INFU
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense InfuSystem Holdings
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 K | -55 K | 2.17 M | 1.4 M | 1.38 M | 1.26 M | 1.9 M | 1.42 M | 1.33 M | 1.34 M | 1.7 M | 3.13 M | 3.5 M | 3.34 M | 2.19 M | 3.35 M | 3.5 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.5 M | -55 K | 1.93 M |
Quarterly Interest Expense InfuSystem Holdings
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 82 K | -54 K | 42 K | -29 K | - | -4 K | -63 K | 3 K | - | -14 K | 2 K | 484 K | - | 385 K | 314 K | 277 K | - | 270 K | 317 K | 322 K | - | 283 K | 332 K | 403 K | - | 488 K | 488 K | 460 K | - | 370 K | 296 K | 315 K | - | 354 K | 333 K | 328 K | - | 384 K | 327 K | 305 K | - | 338 K | 387 K | 672 K | - | 752 K | 776 K | 827 K | - | 838 K | 924 K | 874 K | - | 971 K | 663 K | 601 K | - | 541 K | 564 K | 541 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 971 K | -63 K | 393 K |
Interest Expense of other stocks in the Medical instruments industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
The Cooper Companies
COO
|
-16.4 M | $ 60.84 | 0.76 % | $ 12.1 B |  USA |
 |
Atrion Corporation
ATRI
|
149 | - | - | $ 810 M | USA |
 |
ICU Medical
ICUI
|
93.3 M | $ 122.4 | -0.48 % | $ 3.02 B | USA |
 |
iRhythm Technologies
IRTC
|
5.44 M | $ 114.08 | -0.07 % | $ 3.65 B | USA |
 |
Alcon
ALC
|
204 M | $ 64.65 | 1.02 % | $ 40.4 B |  Schweiz |
 |
Repro Med Systems
KRMD
|
9.91 K | $ 3.91 | -1.75 % | $ 181 M | USA |
 |
LeMaitre Vascular
LMAT
|
5.18 M | $ 99.4 | -0.1 % | $ 2.25 B | USA |
 |
Masimo Corporation
MASI
|
300 K | $ 178.41 | 0.03 % | $ 9.51 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
-26 K | - | - | $ 28.6 M | USA |
 |
Envista Holdings Corporation
NVST
|
-2.3 M | $ 23.9 | 0.21 % | $ 4.02 B | USA |
 |
electroCore
ECOR
|
14.9 K | $ 6.3 | -2.02 % | $ 53.4 K | USA |
 |
Haemonetics Corporation
HAE
|
-9.75 M | $ 57.35 | 0.46 % | $ 2.89 B | USA |
 |
Isoray
ISR
|
84 K | - | 0.03 % | $ 108 M | USA |
 |
Glaukos Corporation
GKOS
|
13.6 M | $ 143.0 | 0.6 % | $ 6.93 B | USA |
 |
STAAR Surgical Company
STAA
|
2.25 M | $ 31.91 | -0.31 % | $ 1.58 B | USA |
 |
STERIS plc
STE
|
8.4 M | $ 216.15 | 0.08 % | $ 21.3 B | USA |
 |
Teleflex Incorporated
TFX
|
85.1 M | $ 130.56 | 0.21 % | $ 5.83 B | USA |
 |
Microbot Medical
MBOT
|
-5 K | $ 1.92 | 3.69 % | $ 87.9 M |  Israel |
 |
Milestone Scientific
MLSS
|
60.3 K | $ 0.34 | -1.02 % | $ 27.9 M | USA |
 |
Merit Medical Systems
MMSI
|
-2.39 M | $ 62.37 | -0.3 % | $ 3.69 B | USA |
 |
Utah Medical Products
UTMD
|
-120 K | $ 63.24 | -0.72 % | $ 205 M | USA |
 |
West Pharmaceutical Services
WST
|
-1 M | $ 301.21 | 0.34 % | $ 21.8 B | USA |
 |
Pulse Biosciences
PLSE
|
-52 K | $ 25.45 | -6.09 % | $ 1.72 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
24 M | $ 10.1 | -3.03 % | $ 2.01 B | USA |
 |
Retractable Technologies
RVP
|
227 K | $ 0.69 | -0.01 % | $ 20.7 M | USA |
 |
Pro-Dex
PDEX
|
533 K | $ 57.73 | -1.57 % | $ 190 M | USA |
 |
Predictive Oncology
POAI
|
3 | - | - | $ 31.1 M | USA |
 |
BioLife Solutions
BLFS
|
1.82 M | $ 20.76 | -1.42 % | $ 991 M | USA |
 |
Stereotaxis
STXS
|
2 K | $ 1.89 | -2.83 % | $ 172 M | USA |
 |
Baxter International
BAX
|
290 M | $ 17.62 | -0.96 % | $ 9.04 B | USA |
 |
ResMed
RMD
|
3.2 M | $ 204.91 | 1.21 % | $ 29.9 B | USA |
 |
AtriCure
ATRC
|
683 K | $ 28.69 | 1.92 % | $ 1.37 B | USA |
 |
Harvard Bioscience
HBIO
|
-2.66 M | $ 5.34 | -3.26 % | $ 237 M | USA |
 |
AngioDynamics
ANGO
|
4.94 M | $ 10.98 | -0.45 % | $ 449 M | USA |
 |
Becton, Dickinson and Company
BDX
|
613 M | $ 143.99 | -0.33 % | $ 41.4 B | USA |
 |
Nephros
NEPH
|
-78 K | $ 3.2 | -4.23 % | $ 34 M | USA |
 |
OraSure Technologies
OSUR
|
229 K | $ 3.04 | 3.05 % | $ 223 M | USA |
 |
Repligen Corporation
RGEN
|
2.82 M | $ 106.8 | 3.31 % | $ 6.01 M | USA |